A new whole genome platform integrates on-flow cell library prep and advanced informatics to deliver comprehensive variant ...

Harvard-trained Nigerian scientist, Dr Olakunle Jaiyesimi, speaks to IBRAHIM ADAM on how leaving Nigeria gave him an insight that expanded his professional capacity, among other issuesWhen did you ...

The last time I spoke about Upstream Bio, Inc. (UPB), it was in a Seeking Alpha article entitled "Upstream Bio: Maintaining Buy Rating On Verekitug Success In Phase 2 CRSwNP Study." With respect to ...

TruPath™ Genome offers more complete genome, with the simplest sample to sequencer workflowData presented at AGBT demonstrates TruPath Genome's accuracy ...

Illumina introduces TruPath Genome, setting a new standard in genomic insight: San Diego Thursday, February 26, 2026, 16:00 Hrs [IST] Illumina, Inc. announced the launch of TruPat ...

Feb 10 (Reuters) - Quest Diagnostics (DGX.N), opens new tab on Tuesday forecast 2026 profit and revenue above Wall Street estimates after beating expectations for fourth-quarter results on strong ...

Upstream Bio said a Phase 2 clinical trial for its respiratory-disease treatment met its primary endpoint in two dosing regimens, but that a third treatment group didn't see consistent improvements.

The VALIANT trial demonstrated statistically significant reductions in the annualized asthma exacerbation rate (AAER) of 56% for the 100 mg every 12 weeks dosing compared to placebo. Additionally, the ...

Artificial intelligence (AI) models for biology rely heavily on large volumes of biological data, including genetic sequences and pathogen characteristics. But should this information be universally ...

Artificial intelligence company Anthropic announced Wednesday that it will ensure consumer electricity costs remain steady as it expands its data center footprint. Anthropic said it would work with ...